The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Gano Kyle since 2013.
This trader's CIK number is 1567160.
At the time of last reporting, Gano Kyle was the Chief Executive Officer of Neurocrine Biosciences Inc. (stock ticker symbol NBIX).
Also see all insider trading activities at Neurocrine Biosciences Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | NBIX | 0 | $0 | 70,079 | $9,848,006 | 74,594 | $2,144,350 |
| 2024 | NBIX | 0 | $0 | 80,473 | $10,614,800 | 75,000 | $1,469,250 |
| 2023 | NBIX | 0 | $0 | 20,677 | $2,145,712 | 0 | $0 |
| 2022 | NBIX | 0 | $0 | 35,146 | $2,971,287 | 28,266 | $244,783 |
| 2021 | NBIX | 0 | $0 | 6,370 | $736,502 | 0 | $0 |
| 2020 | NBIX | 0 | $0 | 12,761 | $1,314,776 | 0 | $0 |
| 2019 | NBIX | 0 | $0 | 4,571 | $399,311 | 0 | $0 |
| 2018 | NBIX | 0 | $0 | 55,587 | $5,677,536 | 51,916 | $449,355 |
| 2017 | NBIX | 0 | $0 | 82,860 | $4,947,452 | 64,818 | $469,898 |
| 2016 | NBIX | 0 | $0 | 46,020 | $2,011,896 | 41,770 | $240,595 |
| 2015 | NBIX | 0 | $0 | 91,105 | $3,642,735 | 63,230 | $263,985 |
| 2014 | NBIX | 0 | $0 | 10,250 | $225,711 | 9,000 | $45,000 |
| 2013 | NBIX | 0 | $0 | 2,400 | $37,464 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-13 | NBIX | Option Ex | 4,807 | .00 | 0 |
| 2025-02-13 | NBIX | Sale | 2,558 | 116.85 | 298,909 |
| 2025-02-08 | NBIX | Option Ex | 1,860 | .00 | 0 |
| 2025-02-10 | NBIX | Sale | 980 | 118.39 | 116,020 |
| 2025-01-31 | NBIX | Sale | 1,541 | 152.87 | 235,577 |
| 2025-01-31 | NBIX | Option Ex | 2,927 | .00 | 0 |
| 2025-01-15 | NBIX | Option Ex | 65,000 | 32.99 | 2,144,350 |
| 2025-01-15 | NBIX | Sale | 65,000 | 141.50 | 9,197,500 |
| 2024-02-13 | NBIX | Sale | 1,352 | 132.90 | 179,674 |
| 2024-02-06 | NBIX | Sale | 1,600 | 142.20 | 227,521 |
| 2024-02-08 | NBIX | Sale | 980 | 134.20 | 131,518 |
| 2024-01-31 | NBIX | Sale | 1,541 | 140.70 | 216,812 |
| 2024-01-02 | NBIX | Option Ex | 75,000 | 19.59 | 1,469,250 |
| 2024-01-02 | NBIX | Sale | 75,000 | 131.46 | 9,859,275 |
| 2023-08-21 | NBIX | Sale | 2,132 | 107.41 | 228,993 |
| 2023-02-06 | NBIX | Sale | 1,600 | 105.64 | 169,027 |
| 2023-02-08 | NBIX | Sale | 980 | 103.99 | 101,910 |
| 2023-02-07 | NBIX | Sale | 14,424 | 102.35 | 1,476,296 |
| 2023-01-31 | NBIX | Sale | 1,541 | 109.98 | 169,486 |
| 2022-02-07 | NBIX | Sale | 5,900 | 80.76 | 476,466 |
| 2022-02-08 | NBIX | Sale | 980 | 79.67 | 78,078 |
| 2022-01-05 | NBIX | Option Ex | 28,266 | 8.66 | 244,783 |
| 2022-01-05 | NBIX | Sale | 28,266 | 85.50 | 2,416,743 |
| 2021-02-05 | NBIX | Sale | 2,677 | 113.93 | 304,979 |
| 2021-02-08 | NBIX | Sale | 3,693 | 116.85 | 431,523 |
| 2020-11-12 | NBIX | Sale | 2,257 | 90.73 | 204,770 |
| 2020-08-05 | NBIX | Sale | 2,257 | 118.87 | 268,285 |
| 2020-04-24 | NBIX | Sale | 1,934 | 99.47 | 192,376 |
| 2020-02-07 | NBIX | Sale | 1,623 | 103.33 | 167,711 |
| 2020-02-05 | NBIX | Sale | 3,690 | 103.04 | 380,221 |
| 2020-02-06 | NBIX | Sale | 1,000 | 101.41 | 101,413 |
| 2019-02-06 | NBIX | Sale | 762 | 83.56 | 63,672 |
| 2019-02-04 | NBIX | Sale | 1,375 | 88.14 | 121,187 |
| 2019-02-05 | NBIX | Sale | 2,434 | 88.11 | 214,452 |
| 2018-08-01 | NBIX | Option Ex | 28,266 | 8.66 | 244,783 |
| 2018-08-01 | NBIX | Sale | 28,266 | 115.00 | 3,250,590 |
| 2018-03-05 | NBIX | Option Ex | 23,650 | 8.65 | 204,572 |
| 2018-03-05 | NBIX | Sale | 23,650 | 90.00 | 2,128,500 |
| 2018-02-05 | NBIX | Sale | 2,046 | 83.08 | 169,987 |
| 2018-01-16 | NBIX | Sale | 1,625 | 79.05 | 128,459 |
| 2017-11-02 | NBIX | Option Ex | 24,818 | 8.65 | 214,799 |
| 2017-11-02 | NBIX | Sale | 24,818 | 71.05 | 1,763,318 |
| 2017-09-06 | NBIX | Option Ex | 20,393 | 8.65 | 176,399 |
| 2017-09-06 | NBIX | Sale | 20,393 | 60.00 | 1,223,580 |
| 2017-09-06 | NBIX | Sale | 4,607 | 60.00 | 276,420 |
| 2017-09-06 | NBIX | Option Ex | 4,607 | 8.65 | 39,850 |
| 2017-05-01 | NBIX | Option Ex | 15,000 | 2.59 | 38,850 |
| 2017-05-01 | NBIX | Sale | 15,000 | 54.00 | 810,000 |
| 2017-04-12 | NBIX | Sale | 13,065 | 50.82 | 663,963 |
| 2017-02-06 | NBIX | Sale | 727 | 43.15 | 31,370 |
| 2017-02-03 | NBIX | Sale | 1,375 | 42.57 | 58,533 |
| 2017-01-17 | NBIX | Sale | 1,625 | 40.65 | 66,056 |
| 2017-01-10 | NBIX | Sale | 1,250 | 43.37 | 54,212 |
| 2016-04-11 | NBIX | Option Ex | 41,770 | 5.76 | 240,595 |
| 2016-04-11 | NBIX | Sale | 41,770 | 43.77 | 1,828,272 |
| 2016-02-03 | NBIX | Sale | 1,375 | 37.98 | 52,222 |
| 2016-01-19 | NBIX | Sale | 1,625 | 46.84 | 76,115 |
| 2016-01-11 | NBIX | Sale | 1,250 | 44.23 | 55,287 |
| 2015-10-16 | NBIX | Sale | 25,000 | 47.77 | 1,194,250 |
| 2015-06-01 | NBIX | Sale | 38,230 | 42.19 | 1,612,923 |
| 2015-06-01 | NBIX | Option Ex | 38,230 | 4.17 | 159,610 |
| 2015-01-16 | NBIX | Sale | 1,625 | 30.80 | 50,050 |
| 2015-01-13 | NBIX | Sale | 25,000 | 30.00 | 750,000 |
| 2015-01-13 | NBIX | Option Ex | 25,000 | 4.17 | 104,375 |
| 2015-01-12 | NBIX | Sale | 1,250 | 28.41 | 35,512 |
| 2014-12-17 | NBIX | Option Ex | 4,957 | 5.00 | 24,785 |
| 2014-12-17 | NBIX | Sale | 4,957 | 22.50 | 111,532 |
| 2014-12-12 | NBIX | Option Ex | 4,043 | 5.00 | 20,215 |
| 2014-12-12 | NBIX | Sale | 4,043 | 22.50 | 90,967 |
| 2014-01-10 | NBIX | Sale | 1,250 | 18.57 | 23,212 |
| 2013-09-04 | NBIX | Sale | 2,400 | 15.61 | 37,464 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gano Kyle (Chief Executive Officer of Neurocrine Biosciences Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.